Various symptoms indicate chronic myelogenous leukemia (CML) has progressed from one phase to another. These include an increase in leukemia cells, a change in a person’s platelet count, and worsening ...

Updated ELVN-001 results showed strong molecular response rates in previously treated CML patients, while the FDA aligned ...

Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. In this type of cancer, the bone marrow produces too many white blood cells. If the disease isn’t effectively treated, it ...

Chronic myeloid leukemia (CML) blast crisis phase is the last stage of the condition where there are large clusters of immature white blood cells, or blasts, in the bone marrow, organs, and tissue.

Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid ...

Articles published in this focus collection were selected from recent issues of Leukemia. They highlight new developments in our understanding and management of persons with CML. CML was the first ...

Experts on chronic myeloid leukemia discuss how caregivers can collaborate with the health care team and support newly diagnosed patients. In your work with caregivers, how have you seen them ...

An update from CML Microsystems ( (GB:CML)) is now available. CML Microsystems reported full-year revenue of £20.45m, down from £22.90m, and a reduced pre-tax loss of £0.07m, but highlighted a strong ...

For the 10–15% of patients with chronic phase CML unable to achieve an adequate response with a tolerable dose of TKI, allogeneic HSCT offers a feasible alternative strategy Early assessment ...